Spire Wealth Management Bio Techne Corp Transaction History

Spire Wealth Management

$2.95 Billion
Q3 2024

A detailed history of Spire Wealth Management transactions in Bio Techne Corp stock. As of the latest transaction made, Spire Wealth Management holds 107 shares of TECH stock, worth $7,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107

Previous 148 27.7%

Holding current value

$7,814

Previous $10,000 20.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$70.96 - $82.35 $2,909 - $3,376	-41 Reduced 27.7%	107 $8,000
Q2 2024 Jul 31, 2024	SELL	$62.12 - $84.15 $1,801 - $2,440	-29 Reduced 16.38%	148 $10,000
Q1 2024 Apr 24, 2024	SELL	$65.98 - $77.09 $3.89 Million - $4.55 Million	-58,995 Reduced 99.7%	177 $12,000
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $3.12 Million - $4.62 Million	59,017 Added 38075.48%	59,172 $4.57 Million
Q3 2023 Nov 08, 2023	SELL	$67.52 - $89.42 $2.46 Million - $3.26 Million	-36,414 Reduced 99.58%	155 $10,000
Q2 2023 Aug 09, 2023	BUY	$73.76 - $85.98 $30,315 - $35,337	411 Added 1.14%	36,569 $2.99 Million
Q1 2023 May 09, 2023	BUY	$71.62 - $86.62 $2.58 Million - $3.12 Million	35,995 Added 22082.82%	36,158 $2.68 Million
Q4 2022 Feb 03, 2023	BUY	$80.67 - $352.29 $10,164 - $44,388	126 Added 340.54%	163 $14,000
Q2 2022 Jul 22, 2022	BUY	$322.67 - $449.65 $322 - $449	1 Added 2.78%	37 $13,000
Q1 2022 Apr 18, 2022	SELL	$353.85 - $487.79 $353 - $487	-1 Reduced 2.7%	36 $16,000
Q2 2021 Jul 26, 2021	BUY	$387.35 - $450.26 $1,162 - $1,350	3 Added 8.82%	37 $17,000
Q1 2021 May 21, 2021	BUY	$314.62 - $411.0 $10,697 - $13,974	34 New	34 $13,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Bio Techne Corp Transaction History